Inhibition of immune checkpoints implicated in immune cells exhaustion inside the tumors such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) or PD-1/PD-L1 pathway has led to durable clinical responses in many cancers and in some cases to long-term remission. Here, CTLA4 is linked to cancer.